DAVION HEALTHCARE PLC (DAVI) IPO — Expected Date, Price Range & Deal Size

DAVION HEALTHCARE PLC (DAVI)

This company has not started trading yet. The live 5-factor QL signal switches on automatically on its first session.

About DAVION HEALTHCARE PLC

Davion Healthcare Plc was originally incorporated in Cyprus as a public limited Company on November 29, 2022 and subsequently re-domiciled its Company headquarters to Ireland in September 2024, maintaining an operation in Cyprus through our wholly owned subsidiary, Davion Healthcare Ltd. We moved the Company from Cyprus to Ireland within the European Union community, where it can more easily focus on developing its range of home tests for a range of home test products, to identify potential medical conditions and provide early warning to enable further clinical examination where applicable.

From DAVION HEALTHCARE PLC's Form F-1/A filed with the SEC on 2025-12-05. The issuer's own words — QuantLogix does not paraphrase it.

Industry

Surgical & Medical Instruments & Apparatus

Headquarters

Clonakilty, Ireland

Incorporated in

Fiscal year ends

December 31

SEC filer

CIK 0002039072

Non-accelerated filer Emerging growth company

The offering

Ticker

DAVI

Exchange

XNAS

Expected listing

2026-10-22tomorrow

Shares offered

25,000,000

Financials, as filed

The audited financial statements for this issuer are in its Form F-1/A filed 2025-12-05. QuantLogix only publishes figures it can read directly from the filing.

QL Listing Score — the prospectus, scored

52/100

Developing · low confidence

The evolution of the private-company QL Score at the point of listing: four evidence pillars read deterministically from the registration statement — growth, revenue quality, technology and risk — weights frozen per version (v1.1.0), pillars with no evidence excluded and reweighted, never defaulted.

Growthno evidence — excluded

Revenue qualityno evidence — excluded

Technology60

technology-language density 6.2/10k words (lexical indicator, not a technical audit)

Risk49

material weakness in internal controls disclosed · 13 related-party transaction mentions · lighter-than-typical hedging language

Foundationno evidence — excluded

✓ No going-concern doubt⚠ Material weakness in controls✓ Single share class✓ No customer-concentration flag◆ Emerging growth company (reduced disclosure)

From DAVION HEALTHCARE PLC's Form F-1/A filed with the SEC on 2025-12-05. Extraction is deterministic — the same filing always produces the same score; 355k characters of the document were scanned. Technology signals are lexical indicators, not a technical audit. Not investment advice; the debut itself will be this score's first grade.

Deal terms come from the public IPO calendar and change up to pricing — an expected date reads “to be announced” until the underwriters set it, and a range is not a final price. Implied market cap and float are arithmetic on those disclosed terms. Nothing on this page is a forecast or a recommendation.